Literature DB >> 30695099

IL-10 promotes malignant pleural effusion in mice by regulating TH 1- and TH 17-cell differentiation and migration.

Xiu-Zhi Wu1, Kan Zhai1, Feng-Shuang Yi1, Zhen Wang1, Wen Wang1, Yao Wang1, Xue-Bin Pei1, Xin-Yu Shi1, Li-Li Xu1, Huan-Zhong Shi1.   

Abstract

The role of IL-10 in malignant pleural effusion (MPE) remains unknown. By using murine MPE models, we observed that an increase in pleural IL-10 was a significant predictor of increased risk of death. We noted that TH 1- and TH 17-cell content in MPE was higher in IL-10-/- mice than in WT mice, and IL-10 deficiency promoted differentiation into TH 1 but not into TH 17 cells. A higher fraction of TH 1 and TH 17 cells in the MPE of IL-10-/- mice expressed CXCR3 compared with WT mice. We also demonstrated that Lewis lung cancer and colon adenocarcinoma cells secreted large amounts of CXCL10, a ligand of CXCR3, which induced the migration of TH 1 and TH 17 cells into the MPE, and IFN-γ could promote this signaling cascade. Furthermore, intrapleural injection of mice with CXCL10-deficient tumor cells led to decreased TH 1- and TH 17-cell content in MPE, increased MPE volume, and reduced survival of MPE-bearing mice. Taken together, we demonstrated that IL-10 deficiency promoted T-cell differentiation into TH 1 cells and upregulated the CXCR3-CXCL10 signaling pathway that recruits TH 1 and TH 17 cells into MPE, ultimately resulting in decreased MPE formation and longer survival time of mice-bearing MPE.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CXCL10; IL-10; Type 1 helper T cells (TH1); Type 17 helper T cells (TH17); malignant pleural effusion

Mesh:

Substances:

Year:  2019        PMID: 30695099     DOI: 10.1002/eji.201847685

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

Review 1.  Th17 cells and their related cytokines: vital players in progression of malignant pleural effusion.

Authors:  Yiran Niu; Qiong Zhou
Journal:  Cell Mol Life Sci       Date:  2022-03-17       Impact factor: 9.261

2.  Downregulation of miR-4772-3p promotes enhanced regulatory T cell capacity in malignant pleural effusion by elevating Helios levels.

Authors:  Wen-Qing Yu; Ning-Fei Ji; Cheng-Jing Gu; Zhi-Xiao Sun; Zheng-Xia Wang; Zhong-Qi Chen; Yuan Ma; Zhen-Zhen Wu; Yan-Li Wang; Chao-Jie Wu; Ming-Dong Ding; Gui-Hong Dai; Juan Yao; Rong-Rong Jin; Mao Huang; Ming-Shun Zhang
Journal:  Chin Med J (Engl)       Date:  2019-11-20       Impact factor: 2.628

3.  Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+ T cells, and M1 macrophages.

Authors:  Martin Hart; Laura Nickl; Barbara Walch-Rueckheim; Lena Krammes; Stefanie Rheinheimer; Caroline Diener; Tanja Taenzer; Tim Kehl; Martina Sester; Hans-Peter Lenhof; Andreas Keller; Eckart Meese
Journal:  J Immunother Cancer       Date:  2020-11       Impact factor: 13.751

4.  IRF4 is Correlated with the Conversion to a Th17-Like Phenotype in Regulatory T Cells from the Malignant Pleural Effusion.

Authors:  Wenqing Yu; Ningfei Ji; Chengjing Gu; Juan Yao; Mingdong Ding; Daming Zhou; Mao Huang; Mingshun Zhang
Journal:  Int J Gen Med       Date:  2021-09-23

5.  Antioxidative enzyme NAD(P)H quinone oxidoreductase 1 (NQO1) modulates the differentiation of Th17 cells by regulating ROS levels.

Authors:  Kyoko Nishida-Tamehiro; Akihiro Kimura; Takeshi Tsubata; Satoru Takahashi; Harumi Suzuki
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

6.  Efferocytosis fuels malignant pleural effusion through TIMP1.

Authors:  Lilan Zhao; Anastasios D Giannou; Yang Xu; Ahmad Mustafa Shiri; Imke Liebold; Babett Steglich; Tanja Bedke; Tao Zhang; Jöran Lücke; Pasquale Scognamiglio; Jan Kempski; Anna Woestemeier; Jing Chen; Theodora Agalioti; Dimitra E Zazara; Diana Lindner; Melanie Janning; Jan K Hennigs; Rajesh M Jagirdar; Ourania S Kotsiou; Sotirios G Zarogiannis; Yasushi Kobayashi; Jacob R Izbicki; Sourav Ghosh; Carla V Rothlin; Lidia Bosurgi; Samuel Huber; Nicola Gagliani
Journal:  Sci Adv       Date:  2021-08-13       Impact factor: 14.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.